FOR IMMEDIATE RELEASE
BECKMAN COULTER LIFE SCIENCES ACQUIRES CYTOBANK
(INDIANAPOLIS, INDIANA – June 4, 2019) – Beckman Coulter Life Sciences today announced its acquisition of Cytobank, a privately held, single cell data analysis, software as a service (SaaS) company based in Santa Clara, California.
We are delighted to announce the release of Cytobank 7.2, with the new Experiment Manager. We’ve been listening, and our latest release includes enhancements that make it easier than ever to manage your data and collaborate on your experiments and insights. More »
Tregs: How Deep Can You Go?
Leverage Machine Learning to Identify Novel Cell Populations
and integrate single-cell
technologies
Wednesday, January 23rd, 2019
10:00AM PST/1:00PM EST/6:00 PM GMT
Included in this release are many performance and interface improvements, as well as a notable new addition to our repertoire of integrated algorithms. As we continue to evolve and improve our platform in response to your needs and feedback, we also look to leaders in our field to expand our capabilities and bring high-level developments in bioinformatics to you in an approachable and easy-to-use way.
In this spirit, we introduce FlowSOM in Cytobank. More »
Free FlowSOM Webinar Wednesday, November 28, 2018 
9:00 AM PST / 12:00 PM EST / 6:00 PM CET
FlowSOM in Cytobank is coming soon!
Sign up now to learn from our scientists and our special guest expert for our next live webinar.
When it is released to all users on Cytobank later this month, the FlowSOM algorithm will speed time to analysis and quality of clustering with self-organizing maps (SOMs) that can reveal how all markers are behaving on all cells, and can detect subsets that might otherwise be missed. If you have a large study with many events per sample or many samples, FlowSOM enables you to include all your data in the analysis, instead of restrictively subsampling. Leveraging the power of the Cytobank cloud, users can scale their compute to run up to 90 million events through FlowSOM in only 3.5 hours More »
By our guest blogger, Ken Stineman*, Ken is Cytobank’s Security Lead.
Cytobank is utilized by most of the top pharmaceutical companies, immunologically-driven biotech companies and many leading academic institutions for analyzing, storing and sharing complex cytometry data generated on their clinical trial specimens. These entities routinely perform rigorous assessments of our security and these complement the testing and evaluation we do in-house. More »
ISAC’s Live Education Delivery Task Force will be hosting the fourth Sino-US Cytometry Workshop in Hangzhou, China October 24th-26th. Be sure to catch our very own Qianjun Zhang as she serves as co-host and speaker at the event. Her session, entitled “Big Data in Single Cell, high dimensional data analysis” will be on Thursday, October 25th at 15:30 local time.
Novel data analysis methods will automate biomarker discovery
to predict patient response in clinical trials
Mountain View, Calif. – August 1, 2108 – Cytobank has been
awarded a $1.3M Phase II SBIR grant from the NIH to scale and add more machine learning algorithms to its popular cloud-based informatics platform. In use at many leading academic institutions and the top ten global pharmaceutical companies, Cytobank’s research platform enables faster, more comprehensive analysis of the high-dimensional single cell datasets captured in immunotherapy clinical trials. There are greater than 1,000 active clinical trials for immunotherapies in oncology alone. More »
